Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Precursor-B Acute Lymphoblastic Leukemia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT04499573
What this trial is testing

Bispecific CD19/CD22 CAR-T for Treatment of Children and Young Adults With r/r B-ALL

Who this might be right for
B-ALL
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 50
Not applicableStudy completedNCT00899496
What this trial is testing

Laboratory Assay in Determining Cancer Resistance in Patients With Metastatic Cancer and in Healthy Participants

Who this might be right for
Cancer
Wake Forest University Health Sciences 54
Not applicableUnknownNCT03413046
What this trial is testing

The Effect of Chemotherapy on Regulatory T Cells

Who this might be right for
Pre B ALLRegulatory T Cell
Ankara Children's Health and Diseases Hematology and Oncology Training and Research Hospital 60
Not applicableLooking for participantsNCT07371403
What this trial is testing

MB-CART19.1 in Relapsed/Refractory Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Lymphoblastic Leukemia RecurrentAcute Lymphoblastic Leukemia Refractory+2 more
King Hussein Cancer Center 12
Testing effectiveness (Phase 2)UnknownNCT05252403
What this trial is testing

Residual Disease Driven Strategy for CARCIK (CD19) in Adults/Pediatric BCP-ALL

Who this might be right for
Acute Lymphoblastic Leukemia
Fondazione Matilde Tettamanti Menotti De Marchi Onlus 35
Early research (Phase 1)Looking for participantsNCT05705570
What this trial is testing

Clinical Trial Using CAR- T Cells for Treatment of Patients With Refractory or Relapsed CD19-positive B Lymphoid Malignancies

Who this might be right for
Acute Lymphoblastic Leukemia, in RelapseAcute Lymphoblastic Leukemia RefractoryB-cell Lymphoma Recurrent+3 more
Nelson Hamerschlak 30
Testing effectiveness (Phase 2)Study completedNCT00003913
What this trial is testing

Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Nonmalignant Hematologic Disease

Who this might be right for
LeukemiaLymphomaMyelodysplastic Syndromes+1 more
Fred Hutchinson Cancer Center 390
Early research (Phase 1)Ended earlyNCT00014560
What this trial is testing

Antibody Therapy in Treating Patients With Refractory or Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

Who this might be right for
LeukemiaLymphoma
Dartmouth-Hitchcock Medical Center 3
Early research (Phase 1)UnknownNCT05727683
What this trial is testing

CD19-targeted CAR T Cells for Patients With Relapsed or Refractory in B-cell Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphocytic Leukemia
Shanghai Ming Ju Biotechnology Co., Ltd. 33
Testing effectiveness (Phase 2)Ended earlyNCT00057954
What this trial is testing

Reduced-Intensity Regimen Before Allogeneic Transplant for Patients With Relapsed Non-Hodgkin's or Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Eastern Cooperative Oncology Group 6
Not applicableUnknownNCT01185886
What this trial is testing

Study of Blood and Tissue Samples in Children With Newly Diagnosed Acute Lymphoblastic Leukemia

Who this might be right for
LeukemiaLymphoma
European Organisation for Research and Treatment of Cancer - EORTC 1,200
Testing effectiveness (Phase 2)Study completedNCT06705530
What this trial is testing

Evaluate the Tolerability, Safety, and Efficacy of an Anti-CD19 CAR-T Product in Patients With B-cell Lymphoproliferative Disorders

Who this might be right for
Non-Hodgkin Lymphoma, B-cellAcute Lymphoblastic Leukemia ALL
National Research Center for Hematology, Russia 58
Testing effectiveness (Phase 2)Study completedNCT00611351
What this trial is testing

Busulfan, Cyclophosphamide, & Antithymocyte Globulin Followed by Stem Cell Transplant in Treating Hematologic Cancer

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+4 more
University of Nebraska 5
Large-scale testing (Phase 3)Looking for participantsNCT03937544
What this trial is testing

Intravenous Autologous CD19 CAR-T Cells for R/R B-ALL

Who this might be right for
Relapsed B Acute Lymphoblastic LeukaemiaRefractory B Acute Lymphoblastic Leukaemia
National University of Malaysia 10
Very early researchLooking for participantsNCT06659653
What this trial is testing

Safety and Efficacy of PRG-2302 for Refractory or Relapsed B-cell Acute Lymphoblastic Leukemia Disease.

Who this might be right for
Acute Lymphoblastic Leukemia
Tan Jie 18
Early research (Phase 1)UnknownNCT00003073
What this trial is testing

Chemotherapy in Treating Young Patients With Recurrent or Refractory Meningeal Leukemia, Lymphoma, or Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsLeukemiaLymphoma+1 more
Pacira Pharmaceuticals, Inc 15
Large-scale testing (Phase 3)UnknownNCT04375683
What this trial is testing

Study of Efficacy and Safety of Flumatinib Combined With Chemotherapy in Ph Positive ALL

Who this might be right for
Acute Lymphocytic Leukemia, Adult B-CellBCR-ABL1 Fusion Protein Expression
Zhongda Hospital 28
Not applicableStudy completedNCT00713505
What this trial is testing

Educational and Skills Training Program for Parents of Childhood Cancer Survivors Who Have Neurobehavioral Dysfunction

Who this might be right for
Cancer SurvivorCognitive/Functional EffectsLeukemia+3 more
City of Hope Medical Center 56
Not applicableStudy completedNCT04748185
What this trial is testing

Immunogenicity and Safety of Commercially Available Vaccines Against SARS-CoV-2 (COVID-19) in Patients With Hematologic Malignancies

Who this might be right for
Monoclonal B-Cell LymphocytosisChronic Lymphocytic Leukemia/Small Lymphocytic LymphomaB-cell Non Hodgkin Lymphoma+1 more
Mayo Clinic 358
Early research (Phase 1)WithdrawnNCT00004114
What this trial is testing

Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMyelodysplastic Syndromes
Jonsson Comprehensive Cancer Center
Next Page